News
- December 3, 2014
- License agreement for development and sale of Teribone™ in Korea
- July 31, 2014
- Application for approval to manufacture and sell XIAFLEX® (collagenase clostridium histolyticum) in Japan
- May 23, 2014
- Construction of a new manufacturing facility for Recomodulin™ anticoagulant intravenous infusion 12800 in Fuji
- March 13, 2014
- Decision of the Supreme Court of California in litigation with Actelion Ltd. of Switzerland
- February 7, 2014
- Completion of the second manufacturing facility at the Nagoya Pharmaceuticals Plant
- January 31, 2014
- Discontinuation of the development of a transdermal patch formulation of Teribone™ human parathyroid hormone